Tech's hottest IPOs of the year, including Beyond Meat and Zoom, dropped on Monday, falling more than the broader market.Technologyread more
"We do not seek conflict with Iran or any other country," Trump tells reporters in the Oval Office.Politicsread more
Stocks in Asia were tepid in Tuesday morning trade, while investors looked toward to a meeting between U.S. President Donald Trump and Chinese President Xi Jinping set to...Asia Marketsread more
Chinese Vice Premier Liu He held a phone conversation with U.S. Trade Representative Robert Lighthizer and U.S. Treasury Secretary Steven Mnuchin, China's Ministry of Commerce...World Economyread more
Sen. Bernie Sanders announced a plan Monday to forgive the country's $1.6 trillion outstanding student loan tab, intensifying the higher education policy debate in the 2020...Personal Financeread more
While earnings usually come in substantially ahead of expectations — as much as 4 or 5 percentage points is not unusual — the downward direction in the outlook doesn't speak...Earningsread more
U.S. President Donald Trump's senior adviser Kellyanne Conway will not testify before the House of Representatives Oversight Committee this week on her alleged violations of...Politicsread more
"We missed being the dominant mobile operating system by a very tiny amount. We were distracted during our antitrust trial. We didn't assign the best people to do the work,"...Technologyread more
PatientsLikeMe was bought by UnitedHealth following a review by Trump's Treasury Department, which scrutinized the start-up because it's backed by Chinese cash.Technologyread more
Some traders think the energy rally is about to wane, despite the sector being one of June's big winners.ETF Edgeread more
Stocks with this one feature are poised to crush the market after a rate cut, according to Goldman Sachs.Marketsread more
The intellectual godfather of a serious court challenge to Obamacare says that if the effort continues to be successful tens of millions of people would be "free" from the law's individual and employer mandates.
Leading critic of the act, Michael Cannon, revealed that eye-popping number Monday, ahead of Tuesday's potentially crippling blow to the health-care reform law.
In Tuesday's 2-1 ruling, a judicial panel said subsidies to buy health insurance coverage can only be granted to people who purchased insurance on an Obamacare exchange run by an individual state or the District of Columbia—not on the federally run exchange.
Tuesday's ruling does not have an immediate effect on the law. The Obama administration is likely to appeal the decision by the U.S. Court of Appeals panel to the full appellate court.
According to Cannon, if the decision is upheld, more than 250,000 firms in those states, which have about 57 million workers, would not be subject to the employer mandate being phased in starting next year. That rule, which hinges on the availability of subsidies on Obamacare exchanges, will compel employers with 50 or more full-time workers to offer affordable health insurance or pay a fine.
And a total of about 8.3 million individuals will be removed from the rule that they have health insurance or pay a fine equal to as much as 1 percent of their taxable income, Cannon said. He added that the number could be a conservative estimate.
The number includes people who were previously uninsured before the exchanges opened last fall and whose options for insurance on the exchanges would not be considered affordable under the law without subsidy assistance.
"Such a ruling would free nearly 1 million Floridians and more than 1.5 million Texans from the individual-mandate tax," Cannon wrote on his Forbes.com blog, Darwin's Fool. "In 2016, it would free families of four earning as little as $24,000 per year from an illegal tax of $2,085."
Cannon did not add together his estimates for how many people would be removed from the employer and individual mandates because there is some overlap between the two groups. But he contrasted the tens of millions of people who would no longer be subject to fines or tax penalties from the mandates with the 4.7 million people who currently receive subsidies for their HealthCare.gov-purchased plans in the 36 states.
"The winners under such a ruling would outnumber the losers by more than 10-to-1," he wrote in the blog.
Even as he released those numbers, Cannon acknowledged to CNBC.com the long odds facing the court challenge attacking the legality of billions of dollars in subsidies.
"My standard response is, the cases against the [subsidies] are iron-clad, which means the odds for our success are a solid 20 percent," the director of health policy studies at the libertarian Cato Institute joked ahead of Tuesday's ruling.
Cannon and Case Western Reserve University law professor Jonathan Adler are the primary authors of the claim that the Affordable Care Act only allows federal tax credits to be issued to people who buy insurance plans on an exchange established by a state—not on one run by the federal government. People received those subsidies if they had low or moderate incomes.
Just 14 states and the District of Columbia set up their own exchanges, and the legality of the subsidies on those markets was not challenged.
The case that was decided Tuesday, Halbig v. Burwell, was the first one of its kind to be decided at the appellate level, and its outcome may play a decisive role in determining whether the issue is ever heard by the U.S. Supreme Court.
All told there are four lawsuits challenging the legality of the HealthCare.gov subsidies that were authorized by an IRS rule have been filed in different federal courts.
Critics of Cannon's argument say that it misreads the overall intent of Obamacare—to offer affordable health insurance to people around the U.S., regardless of whether they buy insurance on a state-run exchange or the federal exchange.
Last week, two analyses underscored the potential effects of the high court ruling against the legality of the subsidies. The consultancy Avalere Health estimated that people who currently receive subsidies in the affected states would see their premium rates rise an average of 76 percent. And the Robert Wood Johnson Foundation and the Urban Institute said that by 2016, about 7.3 million enrollees would lose about $36 billion in subsidies.
In his Forbes.com blog post Monday, Cannon wrote that "a victory for the Halbig plaintiffs would not increase anyone's premiums."
"What it would do is prevent the IRS from shifting the burden of those premiums from enrollees to taxpayers. Premiums from federal-Exchange enrollees would not rise, but those enrollees would face the full cost of their 'ObamaCare' plans," Cannon wrote.
(UPDATED: The contents of this story were updated to reflect the decision by the U.S. Court of Appeals for the District of Columbia Circuit.)
—CNBC's Dan Mangan.